ArchiveSCV
the-signal.com. The Santa Clarita Valley Signal. Back to the collection.

· signalscv.com, Wayback capture

SetPoint Medical’s Progress Fuels Corporate Headquarters Relocation

VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical, a biomedical technology company developing a bioelectronic therapy for inflammatory diseases, announced today the relocation of its corporate headquarters to Mann Biomedical Park in Valencia, California.

The move equips the company with additional offices and creates dedicated space for their maturing R&D, clinical and operational capabilities. SetPoint joins Boston Scientific, MannKind Corporation, Quallion and the Alfred Mann Foundation on the 167-acre campus dedicated to innovation in biomedical research.

“SetPoint’s move is a milestone for the company as we mature from a start-up company to a world-class innovator in bioelectronic medicine”

Tweet this

SetPoint’s new headquarters provides more than 14,000 square feet for the company’s 25 full-time employees, doubling the size of the company’s previous location, also in Valencia. The facility makes room for additional employees as the company grows and allows the company to expand its research and development lab and machine shop and enhance its quality and operations capabilities as the company prepares for clinical trials with its new proprietary bioelectronic medicine platform.

“SetPoint’s move is a milestone for the company as we mature from a start-up company to a world-class innovator in bioelectronic medicine,” said Anthony Arnold, Chief Executive Officer of SetPoint Medical. “The experience among the SetPoint team, along with this state-of-the-art facility, creates an environment where we can best serve our customers and bring to market a safe and effective bioelectronic therapy for chronic inflammatory diseases.”

The campus, originally a secret Lockheed R&D facility, now known as Mann Biomedical Park, was recently purchased by an investment group as a setting dedicated to medical device innovation. The 167-acre campus provides a park-like setting close to major transportation infrastructure and medical device companies like Boston Scientific, Medtronic, Advanced Bionics, St. Jude Medical and others.

SetPoint is developing a novel proprietary bioelectronic medicine platform to treat a variety of inflammation-mediated autoimmune diseases, by activating the body’s natural Inflammatory Reflex to produce a systemic anti-inflammatory effect. The emerging field of bioelectronic medicine aims to address unmet patient needs utilizing digital dose delivery to modulate disease pathways historically treated with drugs.

This information is from a press release sent out by SetPoint Medical.

← Back to 2016

About this record

How it was held, read and classified

Record details

Morris ID
156930
System
Morris section CMS (/section/…/article/… and /archives/…)
Reading copy
signalscv.com
Chosen by: only copy held. On this copy: words 356 (e-mail addresses counted as one token); reader comments 0 (counted, not reproduced here); images 1.
Extracted by
section_cms:articlebody_span
signal-extract/0.15 (2026-11-16)

Other copies

Held
None. The holding has this article from one host only.

How it was classified

Label
clearly-local
Judgment
A machine’s (recorded as machine), kept as one so it can be revisited.
Classifier
signal-localclass/0.7 (2026-11-12)
Local signals
  • url:section_24_local
  • byline:staff_marker [Signal Staff]
  • text:valley_names [1 distinct/2 mentions: Valencia]
National signals
none fired
Scores
local 7, national 0